CLOs on the Move

Ebenezer Ridges

www.fairviewebenezer.org

 
Ebenezer Ridges is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Eagle Lake Boarding Home

Northern Maine General is a non-profit social service organization located in Eagle Lake, Maine. The Maine State Legislature created NMG in 1907. At that time, it was both a hospital and a home for the aged under the care of the Little Franciscan Sisters

Berks Community Health Center

Berks Community Health Center is a freestanding, non-profit Federally Qualified Health Center, providing patient-centered, affordable, high-quality primary health care.

WellAWARE Systems

WellAWARE Systems, in partnership with Volunteers of America (VOA) and The Evangelical Lutheran Good Samaritan Society (GSS), offers the opportunity for enhanced quality of life for our aging population through an innovative approach to wellness and safety for senior living.

Arizona Foundation for Medical Care

Arizona Foundation for Medical Care is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.